| _version_ |
1797085759077875712
|
| author |
Armitage, J
|
| author_facet |
Armitage, J
|
| author_sort |
Armitage, J
|
| collection |
OXFORD
|
| description |
|
| first_indexed |
2024-03-07T02:12:31Z
|
| format |
Journal article
|
| id |
oxford-uuid:a12042f5-e8fd-47d9-a00b-f6f310ea0ec3
|
| institution |
University of Oxford
|
| language |
English
|
| last_indexed |
2024-03-07T02:12:31Z
|
| publishDate |
2008
|
| record_format |
dspace
|
| spelling |
oxford-uuid:a12042f5-e8fd-47d9-a00b-f6f310ea0ec32022-03-27T02:10:47ZCommentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a12042f5-e8fd-47d9-a00b-f6f310ea0ec3EnglishSymplectic Elements at Oxford2008Armitage, J
|
| spellingShingle |
Armitage, J
Commentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia.
|
| title |
Commentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia.
|
| title_full |
Commentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia.
|
| title_fullStr |
Commentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia.
|
| title_full_unstemmed |
Commentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia.
|
| title_short |
Commentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia.
|
| title_sort |
commentary on nice technology appraisal guidance on ezetimibe for the treatment of primary heterozygous familial and non familial hypercholesterolaemia
|
| work_keys_str_mv |
AT armitagej commentaryonnicetechnologyappraisalguidanceonezetimibeforthetreatmentofprimaryheterozygousfamilialandnonfamilialhypercholesterolaemia
|